| P50 | author | Louise Kuhn | Q61451544 |
| | Photini Kiepiela | Q77767253 |
| | Anna Coutsoudis | Q42177417 |
| | Gita Ramjee | Q42571276 |
| P2093 | author name string | Brodie Daniels | |
| | Shabashini Reddy | |
| | Elizabeth Spooner | |
| | Eshia Moodley-Govender | |
| | Linda Zako | |
| | Noluthando Ngomane | |
| P2860 | cites work | Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling | Q26866939 |
| | Breast milk and gut microbiota in African mothers and infants from an area of high HIV prevalence | Q28535435 |
| | The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing | Q29615054 |
| | High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, | Q33326481 |
| | Role of postnatal acquisition of the intestinal microbiome in the early development of immune function. | Q33635276 |
| | Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria. | Q33751658 |
| | Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, Uganda | Q33926411 |
| | Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis | Q34355499 |
| | Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries? | Q34368707 |
| | Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy | Q43542964 |
| | Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection | Q43597700 |
| | Impact of cotrimoxazole prophylaxis on the health of breast-fed, HIV-exposed, HIV-negative infants in a resource-limited setting | Q43621620 |
| | Routinely available cotrimoxazole prophylaxis and occurrence of respiratory and diarrhoeal morbidity in infants born to HIV-infected mothers in South Africa. | Q43739856 |
| | Reduced thymic size but no evidence of impaired thymic function in uninfected children born to human immunodeficiency virus-infected mothers | Q45371185 |
| | Aiming at a moving target: research ethics in the context of evolving standards of care and prevention | Q45712244 |
| | Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants | Q46328518 |
| | Child mortality according to maternal and infant HIV status in Zimbabwe | Q46339318 |
| | Growth Faltering in Rural Gambian Infants Is Associated with Impaired Small Intestinal Barrier Function, Leading to Endotoxemia and Systemic Inflammation | Q47933958 |
| | Evidence of impact of maternal HIV infection on immunoglobulin levels in HIV-exposed uninfected children. | Q53305666 |
| | Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses | Q58590807 |
| | [Complementary feeding] | Q79368157 |
| | Effect of formula composition on the development of infant gut microbiota | Q84143418 |
| | Severe infections in HIV-exposed uninfected infants: clinical evidence of immunodeficiency | Q84229726 |
| | High Incidence of Invasive Group B Streptococcal Infections in HIV-Exposed Uninfected Infants | Q84791566 |
| | Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial | Q34369756 |
| | Human milk: a source of more life than we imagine | Q34524241 |
| | Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial | Q34634644 |
| | Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial | Q34748630 |
| | Mucosal immunity: integration between mother and the breast-fed infant | Q35172894 |
| | Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi | Q35452458 |
| | Health outcomes of HIV-exposed uninfected African infants | Q35825690 |
| | Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection | Q35839094 |
| | Microbial translocation in the pathogenesis of HIV infection and AIDS. | Q36558287 |
| | Protection of the neonate by the innate immune system of developing gut and of human milk | Q36702572 |
| | Role of intestinal mucosal integrity in HIV transmission to infants through breast-feeding: the BAN study | Q37037065 |
| | Gut microbial colonisation in premature neonates predicts neonatal sepsis | Q37047543 |
| | Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease | Q37339874 |
| | Effects of cotrimoxazole prophylactic treatment on adverse health outcomes among HIV-exposed, uninfected infants | Q37555921 |
| | The importance of the development of the intestinal microbiota in infancy | Q37601278 |
| | Breast milk as the gold standard for protective nutrients | Q37682382 |
| | Microbiota-stimulated immune mechanisms to maintain gut homeostasis | Q37775371 |
| | Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana | Q38396143 |
| | Optimal breastfeeding practices and infant and child mortality: a systematic review and meta-analysis | Q38562007 |
| | Effect of exclusive breastfeeding and complementary feeding on infant growth and morbidity. | Q39732369 |
| | Human monocyte CD14 is upregulated by lipopolysaccharide. | Q39824929 |
| | Detection of low-concentration host mRNA transcripts in Malawian children at risk for environmental enteropathy | Q40051745 |
| | Containing antimicrobial resistance: a renewed effort | Q42338259 |
| P433 | issue | 7 | |
| P921 | main subject | child mortality | Q61559 |
| | breastfeeding | Q174876 |
| | maternal health | Q6786626 |
| | study protocol | Q111908491 |
| P304 | page(s) | e010656 | |
| P577 | publication date | 2016-07-12 | |
| P1433 | published in | BMJ Open | Q17003470 |
| P1476 | title | Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol | |
| P478 | volume | 6 | |